Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Neuropathol Exp Neurol. 2013 Nov;72(11):1016-28. doi: 10.1097/NEN.0000000000000000.

Pathogenesis of autosomal dominant hereditary spastic paraplegia (SPG6) revealed by a rat model.

Author information

  • 1From the Department of Neurology, The Ohio State University, Columbus, Ohio (FW, WDA, OG, HM, MS, AH, AH, ZS, YYK); The Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (REH); Department of Pediatrics and Pathology, The Ohio State University/Nationwide Children's Hospital (ZS); and Center for Gene Therapy, The Research Institute, Nationwide Children's Hospital (ZS), Columbus, Ohio.

Erratum in

  • J Neuropathol Exp Neurol. 2014 Feb;73(2):190.

Abstract

Hereditary spastic paraplegias (HSPs) are characterized by progressive spasticity and weakness in the lower extremities that result from length-dependent central to peripheral axonal degeneration. Mutations in the non-imprinted Prader-Willi/Angelman syndrome locus 1 (NIPA1) transmembrane protein cause an autosomal dominant form of HSP (SPG6). Here, we report that transgenic (Tg) rats expressing a human NIPA1/SPG6 mutation in neurons (Thy1.2-hNIPA1) show marked early onset behavioral and electrophysiologic abnormalities. Detailed morphologic analyses reveal unique histopathologic findings, including the accumulation of tubulovesicular organelles with endosomal features that start at axonal and dendritic terminals, followed by multifocal vacuolar degeneration in both the CNS and peripheral nerves. In addition, the NIPA1 mutation in the spinal cord from older Tg rats results in an increase in bone morphogenetic protein type II receptor expression, suggesting that its degradation is impaired. This Thy1.2-hNIPA1 Tg rat model may serve as a valuable tool for understanding endosomal trafficking in the pathogenesis of a subgroup of HSP with an abnormal interaction with bone morphogenetic protein type II receptor, as well as for developing potential therapeutic strategies for diseases with axonal degeneration and similar pathogenetic mechanisms.

PMID:
24128679
[PubMed - indexed for MEDLINE]
PMCID:
PMC3814936
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Write to the Help Desk